Cardiology

Branch of medicine dealing with the heart

Follow Cardiology on Notably News to receive short updates to your email — rarely!

We include updates on Echocardiography, Reflex syncope, Heart rate variability, Sinus rhythm, Low-density lipoprotein, Pulse oximetry, High-density lipoprotein, Cardioversion, Cardiac catheterization, Artificial heart, Catheter ablation, Coronary circulation, Implantable cardioverter-defibrillator, Atrial flutter, Heart sounds, Lipoprotein ... and more.

May 17 2025
World Hypertension Day
World Hypertension Day 2025 was observed with the theme 'Measure Your Blood Pressure Accurately, Control It, Live Longer', focusing on raising global awareness about high blood pressure and its prevention for two decades.
March 2025
Lipoprotein
Eli Lilly announced an experimental drug, lepodisiran, which demonstrated promising results in significantly lowering Lp(a) levels for months after a single injection.
2024 AHA partnered with the Deloitte Health Equity Institute and the Society for Human Resource Management Foundation to launch the Health Equity in the Workforce initiative, providing tools to help employers improve workplace health equity.
2024 Keith B. Churchwell becomes the volunteer president of the American Heart Association
2024 American Heart Association launches its 2024 Impact Goal focused on advancing cardiovascular health equity, aiming to identify and remove barriers to health care access and quality for all people.
October 2024 The American Heart Association announced a grant to improve heart health in rural communities, funding initiatives that address healthcare access and education in underserved areas.
October 31 2024
Aortic valve replacement
Cardiothoracic surgeon Vinay Badhwar performed the first combined robotic aortic valve replacement (RAVR) and coronary artery bypass grafting (CABG) using a da Vinci Xi robot through a single small incision at West Virginia University Heart and Vascular Institute.
June 2024 The American Heart Association celebrated its 100-year anniversary, recognized as the nation's oldest and largest voluntary organization dedicated to fighting heart disease and stroke. The celebration included CPR training events where participants received take-home CPR kits.
March 2024
Impella
FDA issued a warning about Impella left-sided blood pumps being linked to 49 deaths due to left ventricular perforation or wall rupture.
2023 Tiny Tickers was highlighted in Global's Make Some Noise Appeal, with charity staff and supporters interviewed on Heart Radio by Amanda Holden and Jamie Theakston.
2023 NFL player Damar Hamlin, who survived a cardiac arrest during a game, joined the American Heart Association at the Empire State Building for National Wear Red Day to raise awareness about heart health and emergency response.
2023 Launched the R.A.P.I.D.O. Campaign, a Spanish-language awareness campaign targeting Hispanic Americans about stroke symptoms and recognition, providing an educational acronym to help identify potential stroke signs.
2023 Announced the Second Century of Science Initiative to commemorate the AHA's first 100 years, awarding $20 million in grants to over 100 U.S. scientists across three award categories: Second Century Implementation Science Award, Second Century Early Faculty Independence Award, and Clinical Fellow Research Education Program.
2023 The CEO Roundtable expanded to include almost 50 Fortune 100 CEOs, demonstrating significant growth and corporate engagement in workplace health initiatives.
2023 Miss America's Scholarship Foundation announced a 3-year commitment to support the Go Red for Women initiative.
September 2023 The AHA partnered with the National Association of Chain Drug Stores, American Cancer Society, American Diabetes Association, and Tufts University's Food is Medicine Institute to launch 'Nourish My Health', a national public education campaign promoting the health benefits of nutritious food.
July 2023
Impella
FDA issued a Class I recall for all Impella left-sided blood pumps due to risk of motor damage during transcatheter aortic valve replacement.
January 2023 The American Heart Association launched the 'Nation of Lifesavers' program to educate teens and adults about responding to cardiac emergencies, aiming to improve survival rates for out-of-hospital cardiac arrests.
2022 The American Heart Association collaborated with the Rockefeller Foundation, Kroger, and other partners to launch a national Food is Medicine Research Initiative, aiming to provide evidence on how food-as-medicine programs can improve health.
2022 The American Heart Association expanded its health metrics from Life's Essential 7 (LE7) to Life's Essential 8 (LE8) by adding sleep health as a new behavioral metric to its cardiovascular health measurement framework.
2022 Go Red for Women social media channels reached an audience of over 5.3 million.
2022 The annual flagship meeting resumed as an in-person conference after two years of virtual events.
June 2022
Hurst's the Heart
The 15th edition of the book was published under the title 'Fuster and Hurst's The Heart', marking a continued evolution of this important medical text.
2021
Low-density lipoprotein
The United States banned added trans fat (in the form of partially hydrogenated oils), marking a significant regulatory action to reduce harmful dietary fats that can impact LDL cholesterol levels.
2021
Low-density lipoprotein
Scientists demonstrated CRISPR gene editing technique that successfully decreased blood levels of LDL cholesterol by 60% in Macaca fascicularis monkeys by using PCSK9 gene knockout in the liver, with the effect lasting for months.
2021
Wearable cardioverter defibrillator
Cortesi and colleagues published an HTA focusing on the cost-effectiveness of WCD, finding it to be a cost-effective treatment option for patients after myocardial infarction and ICD explantation.
2021
Wearable cardioverter defibrillator
ESC further revised its guidelines on wearable cardioverter defibrillator use, continuing to evolve clinical recommendations based on emerging research and patient needs.
2021
Wearable cardioverter defibrillator
European Society of Cardiology (ESC) further updates guidelines to continue recommending WCD for prevention of SCD.
2021
Cardiovascular Cell Therapy Research Network
Results of the CONCERT-HF study were published in the European Journal of Heart Failure.
2021
Cardiovascular Cell Therapy Research Network
Barry R. Davis completed his leadership term for the Data Coordinating Center of the Cardiovascular Cell Therapy Research Network.
2021 EMPEROR-Preserved trial explored the role of SGLT2 receptors in treating heart failure, expanding potential treatment options.
2021 The annual flagship meeting continued to be held virtually due to the COVID-19 pandemic.
July 2021
Wearable cardioverter defibrillator
FDA approved a second wearable cardioverter defibrillator product by Kestra Medical Technologies, Inc., designed with an alternative fabric and garment style for women.
2020
Advanced cardiac life support
ACLS guidelines were restructured to align with ILCOR recommendations, moving to an online format that allows for continuous evidence-based updates.
2020 ISCHEMIA trial concluded that medical therapy is as effective as coronary stents in stable heart disease.
2020
Wearable cardioverter defibrillator
A per protocol analysis of the VEST Trial was published, revealing a 62% reduction in arrhythmic mortality and a 75% reduction in all-cause mortality when using the WCD.
2020
Wearable cardioverter defibrillator
Aidelsburger and colleagues published a Health Technology Assessment (HTA) analyzing data from 49 studies, concluding the WCD is a safe and effective intervention for sudden cardiac arrest risk management.
2020
Cardiovascular Cell Therapy Research Network
Results of the SENECA study were published in JACC CardioOncology.
2020 ISCHEMIA trial demonstrated that medical therapy can be as effective as coronary stents in managing stable heart disease, potentially changing intervention strategies.
2020 Due to the COVID-19 pandemic, the annual flagship meeting of the organization was held virtually.
2020 CEOs of CVS Health, Walgreens Boots Alliance, and US Foods joined the American Heart Association CEO Roundtable.
2019
Wearable cardioverter defibrillator
Masri et al. conducted a systematic cross-indication review and meta-analysis of WCD studies, analyzing 28 studies and over 30,000 patients.
2019
Cardiovascular Cell Therapy Research Network
Lemuel Moye's leadership of the Data Coordinating Center ended, and Barry R. Davis took over leadership.
2019 The American Heart Association's 'Check. Change. Control.' hypertension management program was utilized by over 315,000 people, promoting blood pressure self-monitoring through an evidence-based approach.
2018
Low-density lipoprotein
A review found a dose-response relationship for phytosterols, confirming that intakes of 1.5 to 3 g/day can lower LDL-C by 7.5% to 12%.
2018
Wearable cardioverter defibrillator
Olgin et al. published the first and only randomized controlled trial (VEST Trial) on Wearable Cardioverter Defibrillator (WCD) use with post-MI patients, involving 2,302 patients in the intention-to-treat analysis.
2018 The organization updated its mission statement to 'To be a relentless force for a world of longer, healthier lives', reflecting an expanded and more proactive approach to cardiovascular health.
2018 The American Heart Association and American College of Cardiology issued new cholesterol management guidelines, including a recommendation to use coronary artery calcium score to assess statin medication needs.
2018 Miss America competition removed the swimsuit portion of the pageant.
February 2018
Impella
FDA approved the sale of Impella ventricular support systems.

We are only showing the most recent entries for this topic.

This contents of the box above is based on material from the Wikipedia articles World Hypertension Day, Lipoprotein(a), Cardiology, American Heart Association, Hurst's the Heart, Advanced cardiac life support, Aortic valve replacement, Wearable cardioverter defibrillator, Cardiovascular Cell Therapy Research Network, Tiny Tickers, Low-density lipoprotein & Impella, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also